Therapeutic Technologies
For incubator and accelerator programs that have startups and research around novel therapeutics focused on rare diseases in the following areas:
_»_Immunology
_»_Hematology
_»_Respiratory
_»_Transplant
_»_Cardiovascular
The company is interested in forming collaborative relationships with business incubators and accelerators at the heart of North America’s vibrant biotechnology innovation ecosystems. Seeking complementary technology to their core business of protein drugs, cell therapies, gene therapies, this global company has key areas in mind for development, including:
1. Access to early-stage innovation to build a research pipeline
2. Identify new external collaborators/key opinion leaders
3. Build brand awareness in North America
The company is not interested in small molecule drugs or medical devices.
The company is seeking vibrant partners willing to form long-term collaborative relationships with key leaders in biotechnology. As they are very specialized in what they do, the company is ultimately seeking strategic alignment that would benefit both parties in the long-run. Over time, the company hopes to connect with relevant startups developing the latest, most disruptive ideas.
May 5, 2021
The company has an amazing European partner and would like to foster more relationships like this in North America.
This is the chance for superstar UBI Global member programs to form a great partnership with a thriving, innovative corporate partner. The call is for YOU to nominate your program and your ecosystem for them to be a long-term inspiration and mentor that, if the circumstances are right, will also form partnerships with your startups.
North America
May 5, 2021
This is a global company with facilities in multiple countries (Australia, Germany, Switzerland, the UK, and the USA)
Community Members – 1 nomination
Pro Members – Up to 5 nominations
Premium Members – Up to 20 nominations